Detalles de la búsqueda
1.
Empagliflozin in Patients with Chronic Kidney Disease.
N Engl J Med
; 388(2): 117-127, 2023 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36331190
2.
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.
J Am Soc Nephrol
; 35(2): 202-215, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38082486
3.
Comparing survival in patients with chronic kidney disease across three countries - Results from the study of heart and renal protection-extended review.
Nephrology (Carlton)
; 28(1): 36-43, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36309984
4.
Study protocol for Vascular Access outcome measure for function: a vaLidation study In hemoDialysis (VALID) : A multi-center, multinational validation study to assess the accuracy and feasibility of measuring vascular access function in clinical practice.
BMC Nephrol
; 23(1): 372, 2022 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36402958
5.
Dietary habits in Australian, New Zealand and Malaysian patients with end stage kidney failure: A pre-specified cross-sectional study of the FAVOURED trial participants.
J Hum Nutr Diet
; 35(6): 1178-1191, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921448
6.
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.
JAMA
; 327(19): 1888-1898, 2022 05 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579642
7.
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics.
Am J Nephrol
; 52(10-11): 827-836, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34731857
8.
A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD).
J Am Soc Nephrol
; 31(11): 2653-2666, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32917784
9.
Identifying critically important vascular access outcomes for trials in haemodialysis: an international survey with patients, caregivers and health professionals.
Nephrol Dial Transplant
; 35(4): 657-668, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31369099
10.
Survival advantage of initiating dialysis in elderly and non-elderly incident end-stage kidney disease patients.
Nephrology (Carlton)
; 25(8): 644-651, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31900988
11.
Prevalence of chronic kidney disease and its associated factors in Malaysia; findings from a nationwide population-based cross-sectional study.
BMC Nephrol
; 21(1): 344, 2020 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32795256
12.
The point-of-care Bilistick method has very short turn-around-time and high accuracy at lower cutoff levels to predict laboratory-measured TSB.
Pediatr Res
; 86(2): 216-220, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30696987
13.
Health related quality of life of dialysis patients in Malaysia: Haemodialysis versus continuous ambulatory peritoneal dialysis.
BMC Nephrol
; 20(1): 151, 2019 04 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31039745
14.
Report of the Standardized Outcomes in Nephrology-Hemodialysis (SONG-HD) Consensus Workshop on Establishing a Core Outcome Measure for Hemodialysis Vascular Access.
Am J Kidney Dis
; 71(5): 690-700, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29478866
15.
Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic Review.
Am J Kidney Dis
; 71(3): 382-391, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29203125
16.
Chronic kidney disease in Asia: Protocol for a collaborative overview.
Nephrology (Carlton)
; 22(6): 456-462, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27187157
17.
Nephrology in the Oceania-South East Asia region: perspectives and challenges.
Kidney Int
; 94(3): 465-470, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30045813
18.
A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia.
Kidney Int
; 84(5): 1034-40, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23760287
19.
Impact of outcome adjudication in kidney disease trials: observations from the Study of Heart and Renal Protection (SHARP).
Kidney Int Rep
; 8(8): 1489-1495, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37538810
20.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Lancet
; 377(9784): 2181-92, 2011 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21663949